Amia Capital LLP Intra Cellular Therapies, Inc. Transaction History

Amia Capital LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$23.34 - $32.22 $466,146 - $643,497	-19,972 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.61 - $31.86 $99,144 - $179,371	-5,630 Reduced 21.99%	19,972 $512,000
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $65,177 - $120,998	-4,542 Reduced 15.07%	25,602 $657,000
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $371,072 - $998,369	30,144 New	30,144 $463,000

399

87.1M

309K

302K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.88B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.